Zhang, X.; Zhang, Y.; Gao, X.; Zhang, Y.; Chen, Y.
Integrated Single-Cell and Transcriptome Sequencing Analyses Identify Dipeptidase 2 as an Immune-Associated Prognostic Biomarker for Lung Adenocarcinoma. Pharmaceuticals 2023, 16, 871.
https://doi.org/10.3390/ph16060871
AMA Style
Zhang X, Zhang Y, Gao X, Zhang Y, Chen Y.
Integrated Single-Cell and Transcriptome Sequencing Analyses Identify Dipeptidase 2 as an Immune-Associated Prognostic Biomarker for Lung Adenocarcinoma. Pharmaceuticals. 2023; 16(6):871.
https://doi.org/10.3390/ph16060871
Chicago/Turabian Style
Zhang, Xiangqian, Yunfan Zhang, Xiaomei Gao, Ye Zhang, and Yongheng Chen.
2023. "Integrated Single-Cell and Transcriptome Sequencing Analyses Identify Dipeptidase 2 as an Immune-Associated Prognostic Biomarker for Lung Adenocarcinoma" Pharmaceuticals 16, no. 6: 871.
https://doi.org/10.3390/ph16060871
APA Style
Zhang, X., Zhang, Y., Gao, X., Zhang, Y., & Chen, Y.
(2023). Integrated Single-Cell and Transcriptome Sequencing Analyses Identify Dipeptidase 2 as an Immune-Associated Prognostic Biomarker for Lung Adenocarcinoma. Pharmaceuticals, 16(6), 871.
https://doi.org/10.3390/ph16060871